- 1、本文档共55页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Lecture 6 * Lecture 6 * Lecture 6 * Lecture 6 * Lecture 14 * Cost-effectiveness analysis: cost, side effects, etc. Lecture 6 * Apply to the RCTs with long-term follow-up (loss to follow-up). Lecture 6 * AGE-STANDARDIZED DISTRIBUTION OF CHARACTERISTICS OF WOMEN PARTICIPATING IN THE NURSES’ HEALTH STUDY IN 1990, ACCORDING TO THE USE OR NONUSE OF POSTMENOPAUSAL HORMONES . Lecture 6 * Lecture 6 * Single Institution vs. Multiple Site Collaborative Controlled Trials Multi-center trials can be beneficial when: Generalization is important Limited number of patients are available from a single clinic We wish to bring together expertise However, multi-center trials add a significant amount of overhead to a study. / /ictrp/en/ https://www.clinicaltrialsregister.eu/index.html Registration of Clinical Trials Data Collection in RCTs Prognostic profile at entry Treatment Outcome Criteria for outcome, data management, and acquisition must explicit and written out. Data Collection – Treatment Data Assigned: The treatment arm/group that the subject was allocated to (placebo or active). Treatment A, Treatment B, or Treatment C Received: The actual treatment that the participant received. During the study, the investigators must assess compliance to the treatment Interview/ specimen collection Outcome Data Look for “improvement”, i.e. the desired effect Also must record any and all “side effects” Beneficial Harmful SAEs (severe adverse events) Intention To Treat (ITT) What do you do with the non-compliers, etc.? Intention to Treat analysis (ITT) – “All patients allocated to each arm of treatment regimen are analyzed together “as intended” upon randomization, whether or not they actually received or completed the prescribed regimen. Failure to follow this step defeats the main purpose and advantage of random allocation and can cause serious bias.” –A Dictionary of Epidemiology, 5th Edition Intention to Treat The validity of a randomized controlled trial depends greatly on t
文档评论(0)